COO vs PODD: fair value comparison
The Cooper Companies, Inc. and Insulet Corporation · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, PODD currently sits closer to the top of our discount ranking. PODD carries the stronger quality grade.
| COO | PODD | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $53.91 | $131.96 |
| 12-month range | $60.19–$83.92 | $148.13–$318.77 |
| Sector rank | #7 of 113 Healthcare | #2 of 113 Healthcare |
| Quality grade | B | A |
| Leverage | Low | Moderate |
| Margin trend | Contracting | Stable |
| Revenue growth | Modest | High |
| RSI zone | Oversold | Neutral |
| 50/200-day trend | Downtrend | Downtrend |
| DCF cross-check | — | Overvalued |
| 52-week position | The bottom quarter | The bottom quarter |
Full single-stock breakdowns: COO fair value analysis · PODD fair value analysis